CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Tyrosine Kinase Inhibitors Chemotherapy | Non Small Cell Lung Cancer | Lung Non-Squamous Non-Small Cell Cancer | Lung Cancer |
---|---|---|---|
camrelizumab + rivoceranib | |||
STAR-001 | |||
PD-L1 inhibitor | |||
Immunotherapy |